EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Diagnostic and Prognostic Role of Combined p16 and MTAP Immunohistochemistry in Melanocytic Tumors of Uncertain Malignant Potential: A Comprehensive Review and Clinical Practice Analysis

Ludovica Pepe, Vincenzo Fiorentino iD, Cristina Pizzimenti iD, Maurizio Martini iD, Mariacarmela Santarpia, Antonina Fazio, Mario Vaccaro iD, Maria Lentini, Antonio Ieni

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27020971 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ludovica Pepe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Anatomic Pathology Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, 98125 Messina, Italy. Hauptthemen laut MEDLINE: Purine-Nucleoside Phosphorylase, Cyclin-Dependent Kinase Inhibitor p16, Melanoma, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanocytic Tumors of Uncertain Malignant Potential (MELTUMPs) remain among the most challenging entities in dermatopathology due to overlapping morphologic features and marked inter-observer variability. This comprehensive review critically assesses the diagnostic and potential prognostic significance of combining p16 and methylthioadenosine phosphorylase (MTAP) immunohistochemistry (IHC) as a practical surrogate for genomic alterations involving the 9p21 (CDKN2A/MTAP) locus. We analyzed the molecular underpinnings of the CDKN2A/MTAP axis and systematically reviewed existing literature to define an integrated IHC strategy for ambiguous melanocytic lesions. The combined use of p16, a sensitive marker of CDKN2A inactivation, and MTAP, a highly specific marker for homozygous 9p21 deletion, was assessed for its diagnostic complementarity and potential clinical utility. p16 IHC demonstrates high sensitivity but limited specificity due to heterogeneous staining in borderline lesions. In contrast, MTAP loss exhibits near-absolute specificity for CDKN2A/MTAP co-deletion, albeit with lower sensitivity. Concordant loss of both markers strongly supports melanoma or high-risk melanocytoma, while MTAP retention may predict responsiveness to adjuvant interferon therapy. Combined p16/MTAP IHC provides a synergistic, biologically grounded approach that refines diagnostic accuracy in MELTUMPs. This dual-marker algorithm promotes a shift from purely morphology-based evaluation toward a reproducible, molecularly informed classification, improving both diagnostic confidence and patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purine-Nucleoside PhosphorylaseCyclin-Dependent Kinase Inhibitor p16MelanomaBiomarkers, TumorSkin NeoplasmsHumansImmunohistochemistryPrognosis

Stichwörter der Autor:innen

9p21 locusCDKN2AMTAP (Methylthioadenosine phosphorylase)Melanocytic Tumors of Uncertain Malignant Potential (MELTUMP)diagnostic uncertaintyp16 immunohistochemistryprognostic markers

Substanzen

Purine-Nucleoside Phosphorylase5'-methylthioadenosine phosphorylaseCyclin-Dependent Kinase Inhibitor p16Biomarkers, TumorCDKN2A protein, human

Autor:innen und Institutionen

  • Anatomic Pathology Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, 98125 Messina, Italy.
  • Anatomic Pathology Unit, Papardo Hospital, 98158 Messina, Italy.
  • Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, 98122 Messina, Italy.
  • Department of Human Pathology, Plastic Surgery Unit, University of Messina, Policlinico Hospital, 98122 Messina, Italy.
  • Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.

ORCID-Profile: Vincenzo Fiorentino, Cristina Pizzimenti, Maurizio Martini, Mario Vaccaro

Zitieren

APA

Pepe, L., Fiorentino, V., Pizzimenti, C., Martini, M., Santarpia, M., Fazio, A., Vaccaro, M., Lentini, M., & Ieni, A. (2026). The Diagnostic and Prognostic Role of Combined p16 and MTAP Immunohistochemistry in Melanocytic Tumors of Uncertain Malignant Potential: A Comprehensive Review and Clinical Practice Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020971

Vancouver

Pepe L, Fiorentino V, Pizzimenti C, Martini M, Santarpia M, Fazio A, et al. The Diagnostic and Prognostic Role of Combined p16 and MTAP Immunohistochemistry in Melanocytic Tumors of Uncertain Malignant Potential: A Comprehensive Review and Clinical Practice Analysis. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020971

BibTeX
@article{Pepe2026,
  author = {Pepe, Ludovica and Fiorentino, Vincenzo and Pizzimenti, Cristina and Martini, Maurizio and Santarpia, Mariacarmela and Fazio, Antonina and Vaccaro, Mario and Lentini, Maria and Ieni, Antonio},
  title = {The Diagnostic and Prognostic Role of Combined p16 and MTAP Immunohistochemistry in Melanocytic Tumors of Uncertain Malignant Potential: A Comprehensive Review and Clinical Practice Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27020971}
}
Kostenlos starten →